As FDA Looks to Congress for CBD Regs, it Elaborates on Potential Paths Forward 

On Thursday, the FDA pushed its desire to work with Congress on cannabinoid product rules, including delta-8 THC.

Regulation
Newsletter, Regulation

Who’s Calling for a Hearing on Rescheduling?

An excerpt from the Cannabis Wire Daily newsletter.

Newsletter

From Congress to Iowa and Colorado, New Battles Brew Over Intoxicating Hemp

An excerpt from the Cannabis Wire Daily newsletter.